Dow Up0.25% Nasdaq Up0.65%

China Biologic Products, Inc. (CBPO)

-NasdaqGS
117.39 Up 1.22(1.05%) 4:00PM EDT
|After Hours : 117.39 0.00 (0.00%) 4:22PM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
China Biologic Products, Inc.
Jialong International Tower
Room 1801
Beijing, 100125
China - Map
Phone: 86 10 6598 3111
Website: http://www.chinabiologic.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:1,667

Business Summary 

China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People’s Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and immunoglobulin for intravenous injection products for original and secondary immunoglobulin deficiency, and auto-immune deficiency diseases; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing human hepatitis B immunoglobulin (pH4) for intravenous injection; human fibrinogen; immune globulin intravenous; human antithrombin III; human cytomegalovirus immunoglobulin; human coagulation factor IX; and human fibrin sealant products. The company sells its products directly, as well as through distributors. China Biologic Products, Inc. is headquartered in Beijing, the People’s Republic of China.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on China Biologic Products, Inc.

Key Executives 
 PayExercised
Mr. Xiaoying Gao , 65
Chairman, Chief Exec. Officer and Pres
1.33M45.72M
Mr. Ming Yang , 44
Chief Financial Officer
669.00K850.00K
Mr. Ming Yin , 38
Sr. Corp. VP and Corp. Sec.
468.00K1.24M
Ms. Zhijing Liu , 62
Corp. VP
222.00K0.00
Mr. Gang Yang , 51
Corp. VP and Gen. Mang. of Guizhou Taibang
406.00K0.00
Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders